Scarica l'app Stockscreener
79.67
0.16%
0.13
Dopo l'orario di chiusura:
79.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NUVL Giù?
Forum
Previsione
Precedente Chiudi:
$79.54
Aprire:
$80.13
Volume 24 ore:
602.94K
Relative Volume:
1.21
Capitalizzazione di mercato:
$5.31B
Reddito:
-
Utile/perdita netta:
$-224.29M
Rapporto P/E:
-20.43
EPS:
-3.9
Flusso di cassa netto:
$-185.06M
1 W Prestazione:
+4.80%
1M Prestazione:
+1.68%
6M Prestazione:
+11.26%
1 anno Prestazione:
-5.81%
Intervallo 1D:
$78.79
$80.66
Intervallo di 1 settimana:
$75.09
$81.10
Portata 52W:
$55.53
$113.51
Nuvalent Inc Stock (NUVL) Company Profile
Nome
Nuvalent Inc
Settore
Industria
Telefono
508-446-2272
Indirizzo
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Confronta NUVL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
79.67 | 5.54B | 0 | -224.29M | -185.06M | -3.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-03-14 | Aggiornamento | UBS | Neutral → Buy |
| 2024-12-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-24 | Iniziato | UBS | Neutral |
| 2024-08-29 | Iniziato | Barclays | Overweight |
| 2024-04-17 | Iniziato | Jefferies | Buy |
| 2024-04-01 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | Ripresa | Guggenheim | Buy |
| 2024-02-23 | Iniziato | Robert W. Baird | Outperform |
| 2023-09-27 | Iniziato | Stifel | Buy |
| 2023-08-08 | Iniziato | SVB Securities | Market Perform |
| 2023-07-24 | Iniziato | Guggenheim | Buy |
| 2023-01-18 | Iniziato | Wedbush | Outperform |
| 2022-06-24 | Iniziato | BMO Capital Markets | Outperform |
Mostra tutto
Nuvalent Inc Borsa (NUVL) Ultime notizie
How to build a custom watchlist for Nuvalent Inc.2025 Volume Leaders & High Conviction Investment Ideas - Newser
Advanced analytics toolkit walkthrough for Nuvalent Inc.Weekly Investment Summary & Free Real-Time Volume Trigger Notifications - Newser
Nuvalent:Raymond James initiates coverage with Outperform rating, PT $105. - AInvest
Chart based exit strategy for Nuvalent Inc.Earnings Summary Report & Daily Oversold Stock Bounce Ideas - Newser
When is the best time to exit Nuvalent Inc.Quarterly Trade Summary & Fast Gain Swing Alerts - Newser
Using portfolio simulators with Nuvalent Inc. includedWeekly Trend Recap & Capital Efficient Trade Techniques - Newser
Market reaction to Nuvalent Inc.’s recent newsRate Hike & Daily Growth Stock Investment Tips - Newser
Raymond James Initiates Nuvalent at Outperform With $105 Price Target - MarketScreener
Can technical indicators confirm Nuvalent Inc.’s reversalGold Moves & Fast Exit Strategy with Risk Control - Newser
Is Nuvalent Inc. stock a value trap2025 Bull vs Bear & Daily Growth Stock Tips - khodrobank.com
How institutional ownership impacts Nuvalent Inc. stockWeekly Gains Report & Stepwise Entry/Exit Trade Alerts - Newser
Momentum divergence signals in Nuvalent Inc. chartJuly 2025 Institutional & Safe Investment Capital Preservation Plans - Newser
Can momentum traders help lift Nuvalent Inc.Market Performance Report & Verified Momentum Watchlists - Newser
Best data tools to analyze Nuvalent Inc. stockQuarterly Performance Summary & Target Return Focused Stock Picks - Newser
Analyzing Nuvalent Inc. with risk reward ratio chartsMarket Performance Summary & Low Risk Investment Opportunities - Newser
Top chart patterns to watch in Nuvalent Inc.July 2025 EndofMonth & Capital Protection Trading Alerts - Newser
Piper Sandler Initiates Nuvalent (NUVL) Amid Key Cancer Drug Catalysts - MSN
Is Nuvalent Inc. stock overvalued or fairly pricedVolume Spike & Weekly Momentum Picks - khodrobank.com
How to use a screener to detect Nuvalent Inc. breakoutsInsider Selling & Fast Gain Swing Alerts - Newser
Nuvalent’s (NUVL) Near-Term Catalysts and Precision Oncology Potential: A Case for Undervalued Upside - AInvest
What does recent volatility data suggest for Nuvalent Inc.2025 Support & Resistance & Low Risk Entry Point Guides - Newser
Can Nuvalent Inc. continue delivering strong returnsOptions Play & AI Driven Price Predictions - khodrobank.com
Is Nuvalent Inc. stock a buy or sell2025 Price Targets & Smart Investment Allocation Tips - khodrobank.com
Is Nuvalent Inc. stock forming a triangle patternJuly 2025 Drop Watch & Intraday High Probability Setup Alerts - khodrobank.com
Is Nuvalent Inc. showing insider buyingJuly 2025 Patterns & Low Drawdown Trading Strategies - خودرو بانک
Is Nuvalent Inc. stock entering bullish territoryMarket Performance Summary & Risk Managed Trade Strategies - Newser
Can Nuvalent Inc. rally from current levelsTrade Volume Report & Capital Efficiency Focused Strategies - Newser
Nuvalent Inc. stock outlook for YEARJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Will Nuvalent Inc. stock recover after recent dropWeekly Market Report & Risk Controlled Swing Alerts - Newser
Measuring Nuvalent Inc.’s beta against major indicesQuarterly Portfolio Report & Stepwise Trade Signal Implementation - Newser
Leading vs lagging indicators on Nuvalent Inc. performancePortfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser
Has Nuvalent Inc. formed a bullish divergenceJuly 2025 Snapshot & Daily Risk Controlled Trade Plans - Newser
What machine learning models say about Nuvalent Inc.Dollar Strength & Community Supported Trade Ideas - Newser
Nuvalent Inc. Sees Spike in Bullish Option Flow getLinesFromResByArray error: size == 0 - newsyoung.net
Nuvalent Inc Azioni (NUVL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nuvalent Inc Azioni (NUVL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Noci Darlene | Chief Development Officer |
Aug 25 '25 |
Option Exercise |
27.85 |
4,000 |
111,400 |
52,034 |
| Noci Darlene | Chief Development Officer |
Aug 25 '25 |
Sale |
74.62 |
4,000 |
298,489 |
48,034 |
| Porter James Richard | President and CEO |
Aug 15 '25 |
Option Exercise |
18.93 |
27,000 |
511,110 |
276,062 |
| Porter James Richard | President and CEO |
Aug 15 '25 |
Sale |
75.42 |
27,000 |
2,036,325 |
249,062 |
| Pelish Henry E. | Chief Scientific Officer |
Aug 07 '25 |
Option Exercise |
27.71 |
5,500 |
152,415 |
66,456 |
| Pelish Henry E. | Chief Scientific Officer |
Aug 07 '25 |
Sale |
74.85 |
5,500 |
411,675 |
60,956 |
| Noci Darlene | Chief Development Officer |
Jul 30 '25 |
Option Exercise |
27.85 |
4,000 |
111,400 |
52,034 |
| Noci Darlene | Chief Development Officer |
Jul 30 '25 |
Sale |
80.36 |
4,000 |
321,440 |
48,034 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):